At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 52 target
Drug / intervention
Ropinirole (+ physical therapy) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Placebo-controlled, Double-blind Pilot Trial to Evaluate the Safety and Efficacy of Ropinirole in Motor Recovery After Stroke
In Brief
A Phase 2 clinical trial evaluating Ropinirole (+ physical therapy) and (vs.) Placebo + physical therapy for Cerebrovascular Accident and Hemiparesis. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Accident, Hemiparesis
CountriesUnited States
CollaboratorsGlaxoSmithKline
Timeline
Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2003
First PostedSep 2005
Primary CompletionFeb 2007
Study CompletionMay 2007
TodayJul 2026
First PostedSep 22, 2005
Enrollment StartOct 1, 2003
Primary CompletionFeb 1, 2007
Study CompletionMay 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 20.8 years ago
Interventions
Ropinirole (+ physical therapy)drug
(vs.) Placebo + physical therapydrug